138 related articles for article (PubMed ID: 33002396)
21. Association of XPC polymorphisms and lung cancer risk: a meta-analysis.
Jin B; Dong Y; Zhang X; Wang H; Han B
PLoS One; 2014; 9(4):e93937. PubMed ID: 24736739
[TBL] [Abstract][Full Text] [Related]
22. Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis.
Zheng W; Cong XF; Cai WH; Yang S; Mao C; Zou HW
Breast Cancer Res Treat; 2011 Aug; 128(3):811-5. PubMed ID: 21318603
[TBL] [Abstract][Full Text] [Related]
23. An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis.
Zhang Y; Wang X; Zhang W; Gong S
Tumour Biol; 2013 Apr; 34(2):973-82. PubMed ID: 23269608
[TBL] [Abstract][Full Text] [Related]
24. [Ala499Val (C > T) and Lys939Gln (A > C) polymorphisms of the XPC gene: their correlation with male infertility].
Liang J; Lu CC; Gu AH; Xia YK; Lü ZM; Xu J; Shi GY; Wang MS; Wang XR
Zhonghua Nan Ke Xue; 2010 Mar; 16(3):244-9. PubMed ID: 20369554
[TBL] [Abstract][Full Text] [Related]
25. A meta-analysis of XPC Lys939Gln polymorphism and melanoma susceptibility.
Jiang W; Zhang H; Chen QW; Xie S
J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1327-31. PubMed ID: 26551988
[TBL] [Abstract][Full Text] [Related]
26. Association between CCND1 and XPC polymorphisms and bladder cancer risk: a meta-analysis based on 15 case-control studies.
Wang Y; Li Z; Liu N; Zhang G
Tumour Biol; 2014 Apr; 35(4):3155-65. PubMed ID: 24264314
[TBL] [Abstract][Full Text] [Related]
27. [Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma].
Li LM; Zeng XY; Ji L; Fan XJ; Li YQ; Hu XH; Qiu XQ; Yu HP
Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):271-5. PubMed ID: 20460046
[TBL] [Abstract][Full Text] [Related]
28. [A 1:1 matched case-control study on the interaction between HBV, HCV infection and DNA repair gene XPC Ala499Val, Lys939Gln for primary hepatocellular carcinoma].
Cai XL; Gao YH; Yu ZW; Wu ZQ; Zhou WP; Yang Y; Xu Y; Song SF; Chen SD
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Sep; 30(9):942-5. PubMed ID: 20193233
[TBL] [Abstract][Full Text] [Related]
29. Ala499Val (C>T) and Lys939Gln (A>C) polymorphisms of the XPC gene: their correlation with the risk of primary gallbladder adenocarcinoma--a case-control study in China.
Jiao X; Ren J; Chen H; Ma J; Rao S; Huang K; Wu S; Fu J; Su X; Luo C; Shi J; Broelsch CE
Carcinogenesis; 2011 Apr; 32(4):496-501. PubMed ID: 21113018
[TBL] [Abstract][Full Text] [Related]
30. Association of XPC Gene Polymorphisms with Colorectal Cancer Risk in a Southern Chinese Population: A Case-Control Study and Meta-Analysis.
Hua RX; Zhu J; Jiang DH; Zhang SD; Zhang JB; Xue WQ; Li XZ; Zhang PF; He J; Jia WH
Genes (Basel); 2016 Sep; 7(10):. PubMed ID: 27669310
[TBL] [Abstract][Full Text] [Related]
31. Modulation of DNA damage/DNA repair capacity by XPC polymorphisms.
Zhu Y; Yang H; Chen Q; Lin J; Grossman HB; Dinney CP; Wu X; Gu J
DNA Repair (Amst); 2008 Feb; 7(2):141-8. PubMed ID: 17923445
[TBL] [Abstract][Full Text] [Related]
32. The association of XPC polymorphisms and tea drinking with colorectal cancer risk in a Chinese population.
Wu Y; Jin M; Liu B; Liang X; Yu Y; Li Q; Ma X; Yao K; Chen K
Mol Carcinog; 2011 Mar; 50(3):189-98. PubMed ID: 21104992
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms in XPC and XPD genes modulate DNA damage in pesticide-exposed agricultural workers of Punjab, North-West India.
Kaur K; Kaur R
Mol Biol Rep; 2020 Jul; 47(7):5253-5262. PubMed ID: 32562175
[TBL] [Abstract][Full Text] [Related]
34. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ
Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216
[TBL] [Abstract][Full Text] [Related]
35. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.
Zhu Y; Lai M; Yang H; Lin J; Huang M; Grossman HB; Dinney CP; Wu X
Carcinogenesis; 2007 Mar; 28(3):698-703. PubMed ID: 17052994
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms in XPC gene and risk for prostate cancer.
Said R; Bougatef K; Setti Boubaker N; Jenni R; Derouiche A; Chebil M; Ouerhani S
Mol Biol Rep; 2019 Feb; 46(1):1117-1125. PubMed ID: 30552616
[TBL] [Abstract][Full Text] [Related]
37. XPD Lys751Gln and Asp312Asn polymorphisms and susceptibility to skin cancer: a meta-analysis of 17 case-control studies.
Zhu HL; Bao JM; Lin PX; Li WX; Zou ZN; Huang YE; Chen Q; Shen H
Asian Pac J Cancer Prev; 2014; 15(16):6619-25. PubMed ID: 25169498
[TBL] [Abstract][Full Text] [Related]
38. Association between three common genetic polymorphisms of XPC and susceptibility to heroin dependency.
Qasemian-Talgard A; Saadat M
Gene; 2020 Jan; 724():144153. PubMed ID: 31610221
[TBL] [Abstract][Full Text] [Related]
39. XPC Lys939Gln polymorphism is associated with the decreased response to platinum based chemotherapy in advanced non-small-cell lung cancer.
Zhu XL; Sun XC; Chen BA; Sun N; Cheng HY; Li F; Zhang HM; Feng JF; Qin SK; Cheng L; Lu ZH
Chin Med J (Engl); 2010 Dec; 123(23):3427-32. PubMed ID: 22166526
[TBL] [Abstract][Full Text] [Related]
40. XPC gene polymorphisms and risk of idiopathic azoospermia or oligozoospermia in a Chinese population.
Liang J; Gu A; Xia Y; Wu B; Lu N; Wang W; Lu C; Zheng Q; Wang S; Wang X
Int J Androl; 2009 Jun; 32(3):235-41. PubMed ID: 18067564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
